Semaglutide + Cagrilintide
Known as CagriSema — semaglutide paired with an amylin peptide, in trials at Novo Nordisk for stronger weight loss.
Best value right now · all sizes
Hydro Research
IN STOCKUNTESTED
Per mg
Vial price5 mg · verified Aug 21
Compare 1 vendor
VendorSizeStock
Semaglutide + Cagrilintide prices verified Aug 21, 2026
$21.25/mgHydro Research · $106.25
Buy best pricePrice movement · 30 daysNot enough history yet to state a trend.Cheapest ever recorded: $25.00/mg on Aug 20. Today matches it.
Quick Summary
Novo Nordisk's next-gen weight-loss combo (CagriSema) — pairs Wegovy's active ingredient with an appetite suppressor for even greater fat loss than either alone. Available from 1 vendor, starting at $125.00.
Research: In the Phase 3 REDEFINE 1 trial (n=3,417), CagriSema achieved 20.4% mean weight loss at 68 weeks, with 60% losing at least 20% and 88% of prediabetic participants returning to normal blood sugar.
Side effects: Nausea, Vomiting, Diarrhea, Constipation, Injection site reactions
Phase 3Novo Nordisk filed for FDA approval Dec 2025 as CagriSema
- 1 of 1 vendor currently have it in stock
- Most common vial size: 5mg
- Category: Weight Loss (GLP-1) — GLP-1 receptor agonists for weight management
Get Semaglutide + Cagrilintide price alerts
Join the list — price-drop alerts for this peptide are in the works and you'll be first on them.